Birthweight and adult health outcomes in a biethnic population in the USA
- PMID: 7926349
- DOI: 10.1007/BF00403383
Birthweight and adult health outcomes in a biethnic population in the USA
Abstract
Recent data indicate that low-birthweight adults are at a higher risk than their high-birthweight peers of developing ischemic heart disease or a cluster of conditions known as the IRS, which includes dyslipidaemias, hypertension, unfavorable body fat distribution and NIDDM. Thus far these observations have been limited to Caucasians from the United Kingdom. we extended these observations to a broader segment of the general population by studying the association of birthweight and adult health outcomes in a biethnic population of the United States. We divided a group of 564 young adult Mexican-American and non-Hispanic white men and women participants of the San Antonio Heart Study into tertiles of birthweight and compared metabolic, anthropometric, haemodynamic, and demographic characteristics across these tertile categories. Additionally, we studied birthweight as a predictor of the clustering of diseases associated with the IRS, defined as any two or more of the following conditions: hypertension, NIDDM or impaired glucose tolerance, dyslipidaemia. Normotensive, non-diabetic individuals whose birthweight was in the lowest tertile had significantly higher levels of fasting serum insulin and a more truncal fat deposition pattern than individuals whose birthweight was in the highest tertile, independently of sex, ethnicity, and current socioeconomic status. Also, the odds of expressing the IRS increased 1.72 times (95% confidence interval: 1.16-2.55) for each tertile decrease in birthweight. These findings were independent of sex, ethnicity, and current levels of socioeconomic status or obesity. In conclusion, low birthweight could be a major independent risk factor for the development of adult chronic conditions commonly associated with insulin resistance in the general population.
Similar articles
-
The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease.Lancet. 1999 May 22;353(9166):1789-92. doi: 10.1016/S0140-6736(98)07546-1. Lancet. 1999. PMID: 10348008 Review.
-
Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study.Diabetologia. 1998 Jun;41(6):694-700. doi: 10.1007/s001250050970. Diabetologia. 1998. PMID: 9662052
-
Are risk factors for conversion to NIDDM similar in high and low risk populations?Diabetologia. 1997 Jan;40(1):62-6. doi: 10.1007/s001250050643. Diabetologia. 1997. PMID: 9028719
-
Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study.Diabetes. 1993 Jan;42(1):154-61. doi: 10.2337/diab.42.1.154. Diabetes. 1993. PMID: 8420812
-
Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.Am J Hypertens. 1992 Mar;5(3):147-53. doi: 10.1093/ajh/5.3.147. Am J Hypertens. 1992. PMID: 1575941
Cited by
-
Weekly prenatal PM2.5 and NO2 exposures in preterm, early term, and full term infants: Decrements in birth weight and critical windows of susceptibility.Environ Res. 2024 Jan 1;240(Pt 1):117509. doi: 10.1016/j.envres.2023.117509. Epub 2023 Oct 26. Environ Res. 2024. PMID: 37890819
-
H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus.Oncol Res. 2023 Mar 1;31(1):23-34. doi: 10.32604/or.2022.028449. eCollection 2023. Oncol Res. 2023. PMID: 37303737 Free PMC article.
-
Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus.Pharmaceuticals (Basel). 2023 Mar 29;16(4):507. doi: 10.3390/ph16040507. Pharmaceuticals (Basel). 2023. PMID: 37111264 Free PMC article.
-
PCB126 exposure during pregnancy alters maternal and fetal gene expression.Reprod Toxicol. 2023 Aug;119:108385. doi: 10.1016/j.reprotox.2023.108385. Epub 2023 Apr 18. Reprod Toxicol. 2023. PMID: 37080397
-
Optimal statin use for prevention of sepsis in type 2 diabetes mellitus.Diabetol Metab Syndr. 2023 Apr 19;15(1):75. doi: 10.1186/s13098-023-01041-w. Diabetol Metab Syndr. 2023. PMID: 37072863 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical